[Retracted] Efficacy and Safety of Amniotic Membrane Transplantation Combined with Closure of Tenon Capsule and Bulbar Conjunctival Space in the Treatment of Primary Pterygium
Table 1
Baseline characteristics.
Characteristics
Treatment group (N = 100) (n (%)/mean ± SD)
Observation group (N = 100) (n (%)/mean ± SD)
t/χ2
P
Age (years)
51.0 ± 7.7
50.2 ± 8.0
0.720
0.472
Weight (kg)
62.1 ± 9.7
63.5 ± 10.2
0.994
0.321
Height (m)
1.69 ± 0.1
1.70 ± 0.2
0.447
0.655
BMI (kg/m2)
22.7 ± 2.5
22.3 ± 2.3
1.177
0.240
Gender
0.328
0.566
Female
56 (56.0)
60 (60.0)
Male
44 (44.0)
40 (40.0)
Drinking
0.367
0.544
No
70 (70.0)
66 (66.0)
Yes
30 (30.0)
34 (34.0)
Smoking
0.024
0.876
No
71 (71.0)
70 (70.0)
Yes
29 (29.0)
30 (30.0)
Type of work
0.734
0.391
Indoor
54 (54.0)
60 (60.0)
Outdoor
46 (46.0)
40 (40.0)
Complications
2.504
0.644
Hypertension
33 (33.0)
38 (38.0)
Diabetes mellitus
3 (3.0)
5 (5.0)
Hyperlipemia
7 (7.0)
12 (12.0)
Meibomian gland dysfunction
84 (84.0)
82 (82.0)
Xerophthalmia
77 (77.0)
70 (70.0)
Pterygium stage
0.276
0.599
Resting
22 (22.0)
19 (19.0)
Active
78 (78.0)
81 (81.0)
Duration of disease (years)
4.6 ± 2.3
4.5 ± 2.4
0.300
0.763
Distance of limbus cornea (mm)
2.5 ± 0.7
2.6 ± 0.5
1.162
0.246
Inserted distance from rectus muscle to limbus corn (mm)
5.16 ± 0.15
5.14 ± 0.12
1.041
0.299
SD, standard deviation; BMI, body mass index; IQR, interquartile range.
